在个性化医学的时代,软组织肉瘤风险分层的机遇和挑战
Avirup Chowdhury1, Khin Thway1,2, Sandro Pasquali3,4
1Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road Sutton, London, SM2 5NG, UK.
Current treatment options in oncology
|July 30, 2024
概括
准确的风险分层对于软组织肉瘤 (STS) 治疗至关重要. 将现有工具与新的分子或免疫学数据相结合,可以改善患者的治疗结果,并指导临床决策.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 软组织肉瘤 (STS) 是一种罕见的,异质的癌症,治疗进展有限.
- 新辅助化疗在STS中的作用仍然存在争议.
- 准确的风险分层对于个性化的术后治疗策略至关重要.
研究的目的:
- 突出软组织肉瘤风险分层的重要性.
- 讨论当前临床病理风险工具 (如Sarculator) 的局限性.
- 探索将新型分子和免疫学数据与现有工具集成的潜力.
主要方法:
- 审查软组织肉瘤当前的风险分层工具.
- 在风险评估中讨论临床病理学,分子学和免疫学数据.
- 考虑风险分层工具的临床转化因素.
主要成果:
- 目前的风险分层工具 (例如,Sarculator) 依赖于临床病理学数据,并且可以是特定于地点/组织学.
- 新兴工具利用分子或免疫学数据进行增强的风险评估.
- 结合多种数据来源,可以识别具有不同结果的新型患者子组.
结论:
- 整合多种风险分层方法,包括新型数据类型,有望改善STS患者管理.
- 成功的临床实施需要证明实用性,经济价值和适应现有途径的适应性.
- 未来的研究应该集中在数据集成和验证工具在现实世界的设置.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


